✦ LIBER ✦

Open-label, dose-titration and continuation study to assess efficacy, safety, and pharmacokinetics of anagrelide in treatment-naïve Japanese patients with essential thrombocythemia

✍ Scribed by Shinichiro Okamoto, Yoshitaka Miyakawa…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A baseline-controlled, open-label, flexi

✍ Benchekroun, A; Faik, M; Benjelloun, S; Bennani, S; El Mrini, M; Smires, A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Efficacy and Safety of Oxybutynin Transd

✍ Michael J. Kennelly; Gary E. Lemack; Jenelle E. Foote; Cynthia S. Trop 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 337 KB

A multicenter open-label phase I/II stud

✍ Der-Yuan Chen; Ning-Sheng Lai; Ling-Ying Lu; Hsiu-Cheng Chou; Yi-Hsing Chen; Tsu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Chinese ⚖ 428 KB

A multicenter, open-label, dose-ranging

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 329 KB

An open-label, randomized, flexible-dose

✍ I. Eardley; P. Wright; R. MacDonagh; J. Hole; A. Edwards 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Erratum to: A multicenter, open-label, d

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 75 KB